Earnshaw SR, Beard SM, Gaffney L, Krishnan A, Hogue SL. The impact of premature discontinuation of antidepressant therapy in major depressive disorder in the UK. Poster presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. [abstract] Value Health. 2004 Nov; 7(6):A779.
Bartosch WJ, Bray JW, Davis KL, Graver L, Schroeder D, Miller K. Variations in mental health and substance abuse service provider types between medicaid and state agencies in three states. Presented at the 132nd Annual Meeting of the American Public Health Association; November 2004.
Burdett AN, Gard CC, Longo CJ, Raskin J, Gilsenan A, Hopkins JS, Miller DP. Prevalence and costs of difficult-to-treat depression in a Canadian claims database. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.
Fehnel SE, Victor T, Manjunath R, Mullen J. Development of a patient-reported instrument to assess the functional status of patients with bipolar disorder. Presented at the ISOQOL 2004 Symposium; June 27, 2004.
Manjunath R, Kim S, Zhou X, Schnoll S. Societal burden of prescription drug misuse and abuse: a prevalence study of prescription analgesics and anxiolytics. Presented at the 66th Annual Scientific Meeting of the College on Problems of Drug Dependence; June 12, 2004. San Juan, PR.
Fehnel SE, Victor T, Manjunath R, Sechrest L, Haynes S, Strakowski S. The development of a patient-reported instrument to assess the functional status of patients with bipolar disorder. Presented at the International Society for Quality of Life Research (ISOQOL) 2004 Symposium, Stating the Art: Advancing Outcomes Research Methodology and Clinical Applications; June 1, 2004. Boston, MA.
McLeod LD, Fehnel SE. Defining minimal clinically important differences: does item response theory have the answer? Presented at the International Meeting of the Psychometric Society; June 1, 2004.
Williams VSL, Fehnel SE, Hollis KA, Hogue SL. Antidepressant-induced sexual dysfunction (ADSD) in Europe: a preliminary investigation. Poster presented at the 2004 ISPOR 9th Annual International Meeting; May 16, 2004. Arlington, VA. [abstract] Value Health. 2004 May; 7(4):361-2.
Morlock R, Feltner D, Fehnel SE, Williams VS, Cappelleri JC, Harness J. Assessing onset of symptom relief in patients with generalized anxiety disorder. Poster presented at the Annual Meeting of the American Psychiatric Association; May 2004. Previously presented at the Anxiety Disorders Association of America.
Earnshaw SR, Krishnan A, Hogue SL, Williams JW. The impact of premature discontinuation of antidepressant therapy in major depressive disorder. Poster presented at the 2004 ISPOR 9th Annual International Meeting; May 16, 2004. Arlington, VA. [abstract] Value Health. 2004 May; 7(3):267.
Snyder ES, Pearson JD, Xu W, Cai B, DeMuro-Mercon CJ, Morrison M. A new single-item sleep quality scale: validation results in chronic primary insomnia and depressed patients. Presented at the Associated Professional Sleep Societies; May 2004.
Mansfield CA, Johnson FR, Van Houtven GL. Behavioral reactions to ozone alerts. Presented at the Southern Economic Association Meetings; April 2004. New Orleans, LA. Previously presented at the University of Massachusetts.
Beatty DL, Williams VS. Social support and alcohol consumption among black students attending a historically black university. Poster presented at the Annual Meeting of the Society for Behavioral Medicine; April 2004.
Garcia-Esteve LL, Navarro P, Ascaso C, Aguado JA, Plaza A, Torres A. Prevalence of postpartum psychiatric morbidity in Spanish mothers. Poster presented at the 12th AEP Congress; April 14, 2004. Geneva, Switzerland. [abstract] Eur Psychiatry. 2004 Apr; 19(Suppl 1):209S.
Garcia-Esteve LL, Navarro P, Ascaso C, Aguado JA, Unizony M, Matrai S. Validation of the Edinburgh Postnatal Depression Scale (EPDS) for detection of postpartum psychiatric morbidity in Spanish mothers. Poster presented at the 12th AEP Congress; April 2004. Geneva, Switzerland. [abstract] Eur Psychiatry. 2004 Apr; 19(Suppl 1):208S-9S.
Morlock R, Feltner D, Fehnel SE, Williams VS, Cappelleri J, Harness J. Assessing onset of symptom relief in patients with generalized anxiety disorder. Poster presented at the Anxiety Disorders Association of America; March 2004.
Williams VSL, Fehnel SE, Hollis KA, Hogue SL. Antidepressant induced sexual dysfunction in Europe: a preliminary investigation. Eur Neuropsychopharmacol. 2004 Jan 1;14:S180.
Mladsi DM, Grogg AL, Irish WD, Lopez RB, Degen K, Swann A, Nimsch CT. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Curr Med Res Opin. 2004 Jan 1;20(12):1883-93. doi: 10.1185/030079904X11510.
Mast TC, DeMuro-Mercon CJ, Pendergast K, Santanello NC. The spectrum of hpv-related psychosocial impact among women. Poster presented at the Papillomavirus 21st International Conference and Clinical Workshop; 2004.